Insufficient fluconazole levels in pediatric patients with cancer treated for invasive candidiasis
the ONA take:
According to a new study published in the journal Clinical Infectious Diseases, researchers have found that the fluconazole concentration in pediatric patients with cancer and invasive candidiasis is not sufficient for treatment with the currently recommended dosing regimen.
For the study, researchers identified 99 critically ill pediatric patients treated with fluconazole from January 2007 to October 2013. Of the 99 patients, 40% had subtherapeutic fluconazole plasma concentrations. Analyses demonstrated a significant and positive association between fluconazole trough concentration and dose (P < 0.001), weight (P = 0.009) and the serum urea concentration (P = 0.003).
In addition, there was a significant and negative association between fluconazole trough concentration and age (P = 0.004) and cancer as the underlying cause of invasive candidiasis (P = 0.003). In addition, they found that a higher fluconazole trough concentration was linked with a decreased duration to culture conversion (HR = 1.076, 95% CI 1.017 - 1.138, P = 0.011).
The findings suggest that a higher dose of fluconazole is necessary to achieve sufficient drug concentrations for the treatment of invasive candidiasis in critically ill pediatric patients with cancer.
Fluconazole in pediatric patients with cancer and invasive candidiasis is not sufficient for treatment.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|